Stock Scheduled Dividends 09/13/2019 09/16/2019 SVJTY

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Rethinking Furniture Comfort: Not Just a Luxury Diving into the world of custom upholstered furniture with insights from Randy Marohn is like finding a cheat sheet for comfort. Seriously, it ain't just about plush cushions or slick fabrics—it's a bonafide science. Marohn, from Sans Furniture Inc. in good ol’ Hamburg, NY, unfolds a tale of intentional design and...

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Innovating Precision in cfDNA Sequencing One day you're trudging along old paths, and the next, technology throws you a curveball that's too critical to ignore. That's the scene at Dana-Farber Cancer Institute with their latest lab upgrade. They've bent the knee to integrate n6's iconPCR system into their toolkit for liquid biopsy research—a move that's caught my...

GlycoMimetics Stock Hits Troubling Low GlycoMimetics Inc. (NASDAQ: GLYC) has seen its stock fall to a concerning 52-week low of just $0.14. This steep decline of -88.71% over the past year has raised alarm among investors. The biotechnology company, known for its focus on glycomimetics, is currently facing significant scrutiny as it works through these troubling times....

Advancements in Cancer Treatment by Medicenna Medicenna Therapeutics is making significant strides in immunotherapy with its groundbreaking MDNA113 and MDNA11 programs. MDNA113, a tumor-targeted and ‘masked’ BiSKIT (Bifunctional SuperKine for ImmunoTherapy), is engineered to deliver anti-PD1-IL-2 Superkine specifically to the tumor microenvironment (TME). This...

Viking Therapeutics Shares Insights on VK2735 Obesity Program Viking Therapeutics, Inc. (NASDAQ: VKTX), a biopharmaceutical company dedicated to innovative treatments for metabolic and endocrine disorders, is excited to announce presentations at two prestigious events in 2025. The company's VK2735 program is poised to take center stage at ObesityWeek 2025, occurring from...

ERMProtect Expands Its Cybersecurity Arsenal A cybersecurity firm that knows its stuff, ERMProtect, has teamed up with NimbusDDOS, the big dog in DDoS preparedness. Why does this matter, you ask? Because keeping your systems online amidst a digital pummeling isn’t just smart business—it's become a regulatory headache. Understanding the Need for DDoS Resilience Nobody...

Partnership Revolutionizes the Equestrian World In a groundbreaking move, ShaikhTech and Cavago are joining forces to advance digital technology in the equine industry. Their partnership promises to bring transformative 3D digital experiences to equestrians and horse enthusiasts worldwide. The Mission of Cavago Cavago is dedicated to modernizing the equestrian experience...